Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis

BACKGROUND: Grass pollen-induced allergic rhinoconjunctivitis constitutes a large burden for society. Up to 20% of European and United States (US) populations suffer from respiratory allergies, including grass pollen-induced allergic rhinoconjunctivitis. The majority of patients are treated with sym...

Descripción completa

Detalles Bibliográficos
Autores principales: Rønborg, Steen M, Svendsen, Ulrik G, Micheelsen, Jesper S, Ytte, Lars, Andreasen, Jakob N, Ehlers, Lars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2012
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500916/
https://www.ncbi.nlm.nih.gov/pubmed/23166443
http://dx.doi.org/10.2147/CEOR.S34832

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500916/
https://www.ncbi.nlm.nih.gov/pubmed/23166443
http://dx.doi.org/10.2147/CEOR.S34832

Ejemplares similares